[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
Teschner
M
M
Nephrologische Abteilung, Medizinischen Universitätsklinik Würzburg.
Schaefer
R M
RM
Bahner
U
U
Heidland
A
A
D000419:Albuminuria / Q000209:etiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000235:genetics; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D004232:Diuretics / Q000627:therapeutic use; D010450:Endopeptidases / Q000378:metabolism; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000201:enzymology; D008790:Metoprolol / Q000627:therapeutic use; D051381:Rats; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D006830:Hydralazine; D005665:Furosemide; D010450:Endopeptidases; D008790:Metoprolol
Nephropathie bei Typ-I-Diabetes. Aktuelle experimentelle und klinische Aspekte.